- Home
- DOLE vs XERS Comparison
DOLE vs XERS Comparison
Compare DOLE & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOLE
- XERS
- Stock Information
- Founded
- DOLE 1851
- XERS 2005
- Country
- DOLE Ireland
- XERS United States
- Employees
- DOLE N/A
- XERS N/A
- Industry
- DOLE Farming/Seeds/Milling
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- DOLE Consumer Staples
- XERS Health Care
- Exchange
- DOLE Nasdaq
- XERS Nasdaq
- Market Cap
- DOLE 1.4B
- XERS 1.3B
- IPO Year
- DOLE 2021
- XERS 2018
- Fundamental
- Price
- DOLE $13.55
- XERS $7.85
- Analyst Decision
- DOLE
- XERS Strong Buy
- Analyst Count
- DOLE 0
- XERS 7
- Target Price
- DOLE N/A
- XERS $8.00
- AVG Volume (30 Days)
- DOLE 1.1M
- XERS 2.8M
- Earning Date
- DOLE 08-11-2025
- XERS 08-07-2025
- Dividend Yield
- DOLE 2.52%
- XERS N/A
- EPS Growth
- DOLE N/A
- XERS N/A
- EPS
- DOLE 0.25
- XERS N/A
- Revenue
- DOLE $8,757,709,000.00
- XERS $246,025,000.00
- Revenue This Year
- DOLE $6.98
- XERS $43.89
- Revenue Next Year
- DOLE $1.91
- XERS $20.40
- P/E Ratio
- DOLE $53.05
- XERS N/A
- Revenue Growth
- DOLE 4.75
- XERS 35.62
- 52 Week Low
- DOLE $12.20
- XERS $2.48
- 52 Week High
- DOLE $17.12
- XERS $8.03
- Technical
- Relative Strength Index (RSI)
- DOLE 39.56
- XERS 72.53
- Support Level
- DOLE $13.09
- XERS $7.67
- Resistance Level
- DOLE $14.77
- XERS $8.03
- Average True Range (ATR)
- DOLE 0.30
- XERS 0.27
- MACD
- DOLE -0.10
- XERS -0.06
- Stochastic Oscillator
- DOLE 23.87
- XERS 76.32
About DOLE Dole plc
Dole PLC operates in the North American and European markets for fresh fruits and vegetables. The company's segment includes Fresh Fruit; Diversified Fresh Produce - EMEA; Diversified Fresh Produce - Americas and ROW. It generates maximum revenue from the Diversified Fresh Produce - EMEA segment. Diversified Fresh Produce - EMEA segment includes Dole's Irish, Dutch, Spanish, Portuguese, French, Italian, U.K., Swedish, Danish, South African, Eastern European, and Brazilian businesses, the majority of which sell a variety of imported and local fresh fruits and vegetables through retail, wholesale and, in some instances, food service channels across the European marketplace.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).